552595283	552595283	CD	B-NP	O
|	|	NN	I-NP	O
EMC	EMC	NN	I-NP	O
|	|	NN	I-NP	O
84531910	84531910	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2129947	2129947	CD	B-NP	O
|	|	CC	I-NP	O
6/10/2007	6/10/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Hypertension	Hypertension	NNP	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
generalized	generalize	VBN	B-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/28/2007	8/28/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/18/2007	2/18/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
MAZARIEGO	MAZARIEGO	NN	B-NP	O
,	,	,	O	O
ALPHONSE	ALPHONSE	NN	B-NP	O
126-00-53-3	126-00-53-3	CD	I-NP	O
Verjer	Verjer	NNP	I-NP	O
Hou	Hou	NNP	I-NP	O
Grand	Grand	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/28/07	7/28/07	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARIONI	MARIONI	NNP	B-NP	O
,	,	,	O	O
ANTON	ANTON	NNP	B-NP	O
DARRON	DARRON	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ATORVASTATIN	ATORVASTATIN	NN	B-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

THERAPEUTIC	THERAPEUTIC	NN	B-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

ALBUTEROL	ALBUTEROL	NN	B-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	I-protein
QID	QID	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

AQUAPHOR	AQUAPHOR	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
APPLICATION	APPLICATION	NN	I-NP	I-protein
TOP	TOP	NN	I-NP	I-protein
AS	AS	NNS	I-NP	I-protein
NEEDED	NEEDED	VBD	B-VP	O
5	5	CD	B-NP	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O

BETAMETHASONE	BETAMETHASONE	NN	B-NP	O
VALERATE	VALERATE	NN	I-NP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
OINTMENT	OINTMENT	NN	I-NP	O
1	1	CD	I-NP	O
APPLICATION	APPLICATION	NN	I-NP	O
TOP	TOP	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

CALCIUM	CALCIUM	NN	B-NP	B-protein
CARBONATE	CARBONATE	NN	I-NP	I-protein
1250	1250	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
500MG	500MG	NN	I-NP	I-protein
ELEM	ELEM	NN	I-NP	I-protein
CA	CA	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
/	/	SYM	B-VP	O
VIT	VIT	NN	B-NP	B-protein
D	D	NN	I-NP	I-protein
200	200	CD	B-NP	I-protein
IU	IU	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	O	O

CLOBETASOL	CLOBETASOL	NN	B-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
1	1	CD	B-NP	O
APPLICATION	APPLICATION	NN	I-NP	O
TOP	TOP	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

DOCUSATE	DOCUSATE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

DIGOXIN	DIGOXIN	NN	B-NP	O
0.25	0.25	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

FERROUS	FERROUS	DT	B-NP	O
SULFATE	SULFATE	JJ	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

FLUTICASONE	FLUTICASONE	NNP	B-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
NAS	NAS	NNP	I-NP	O
BID	BID	NNP	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NN	B-NP	B-protein
REGULAR	REGULAR	NN	I-NP	I-protein
HUMAN	HUMAN	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
UNITS/10	UNITS/10	NNP	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
BID	BID	NNP	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

LACTULOSE	LACTULOSE	NN	B-NP	B-protein
30	30	CD	I-NP	I-protein
ML	ML	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	RB	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QAM	QAM	NN	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

METOPROLOL	METOPROLOL	NN	B-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

CLOTRIMAZOLE	CLOTRIMAZOLE	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TOP	TOP	NN	I-NP	O
BID	BID	NN	I-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

POLYETHYLENE	POLYETHYLENE	NN	B-NP	B-protein
GLYCOL	GLYCOL	NN	I-NP	I-protein
17	17	CD	I-NP	I-protein
GM	GM	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
X1	X1	NN	I-NP	O
20	20	CD	I-NP	O
.	.	.	O	O

INSULIN	INSULIN	NN	B-NP	B-protein
NPH	NPH	NN	I-NP	O
HUMAN	HUMAN	NN	I-NP	O
65	65	CD	I-NP	O
UNITS/68	UNITS/68	NN	I-NP	O
UNITS	UNITS	NN	I-NP	O
SC	SC	NN	I-NP	O
AM/PM	AM/PM	NN	I-NP	O
21	21	CD	I-NP	O
.	.	.	O	O

PETROLATUM/LANOLIN	PETROLATUM/LANOLIN	NN	B-NP	O
1	1	CD	I-NP	O
APPLICATION	APPLICATION	NN	I-NP	O
TOP	TOP	NN	I-NP	O
Q6H	Q6H	NN	I-NP	O
22	22	CD	I-NP	O
.	.	.	O	O

PANTOPRAZOLE	PANTOPRAZOLE	NN	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
23	23	CD	I-NP	O
.	.	.	O	O

SARNA	SARNA	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
APPLICATION	APPLICATION	NN	I-NP	I-protein
TOP	TOP	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
24	24	CD	I-NP	I-protein
.	.	.	O	O

SIMETHICONE	SIMETHICONE	NN	B-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
,	,	,	O	O
Headache	Headache	NNP	B-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	O
INHALER	INHALER	NN	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Shortness	Shortness	NNP	I-NP	O
of	of	IN	B-PP	O
Breath	Breath	NNP	B-NP	O
LIPITOR	LIPITOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
CARBONATE	CARBONATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEMENTAL	ELEMENTAL	NN	I-NP	O
CA	CA	NN	I-NP	O
+	+	SYM	B-VP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	O	O
500	500	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
LOTRIMIN	LOTRIMIN	NN	I-NP	O
1	1	CD	B-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
-LRB-	-LRB-	SYM	B-VP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NN	B-NP	O
1	1	CD	I-NP	O
%	%	NN	I-NP	O
CREAM	CREAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
to	to	TO	B-PP	O
vagina	vagina	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/28/07	7/28/07	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
SERIOUS	SERIOUS	NNS	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
CLOTRIMAZOLE	CLOTRIMAZOLE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
DIGOXIN	DIGOXIN	NN	B-NP	B-protein
0.125	0.125	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2/16	2/16	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
COLACE	COLACE	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	B-protein
FLONASE	FLONASE	NNP	I-NP	I-protein
NASAL	NASAL	NNP	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FLUTICASONE	FLUTICASONE	NNP	I-NP	I-protein
NASAL	NASAL	NNP	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
SPRAY	SPRAY	NNP	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
LASIX	LASIX	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
2/16	2/16	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
65	65	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
LOPRESSOR	LOPRESSOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	B-NP	O
100	100	CD	B-NP	O
or	or	CC	O	O
HR	HR	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NTG	NTG	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	:	O	I-protein
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	I-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
PROTONIX	PROTONIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
MIRALAX	MIRALAX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
POLYETHYLENE	POLYETHYLENE	NNP	I-NP	O
GLYCOL	GLYCOL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
17	17	CD	I-NP	O
GM	GM	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
MULTIVITAMIN	MULTIVITAMIN	NN	I-NP	O
WITH	WITH	NN	I-NP	O
MINERALS	MINERALS	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERA	THERA	NN	I-NP	O
...	...	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
should	should	MD	B-VP	O
measure	measure	VB	I-VP	O
weight	weight	NN	B-NP	O
daily	daily	JJ	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
supervision	supervision	NN	B-NP	O
and	and	CC	I-NP	O
assistance	assistance	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Javier	Javier	NNP	I-NP	O
Garelik	Garelik	NNP	I-NP	O
10/13	10/13	CD	I-NP	O
@	@	NN	I-NP	O
945am	945am	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
WARFARIN	WARFARIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
,	,	,	O	O
PROPOXYPHENE	PROPOXYPHENE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
LISINOPRIL	LISINOPRIL	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Weakness	Weakness	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pulmonary	Pulmonary	NNP	I-NP	O
Hypertension	Hypertension	NNP	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
generalized	generalize	VBN	B-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
chronic	chronic	JJ	I-NP	O
Afib	Afib	NNP	I-NP	O
G-E	G-E	NN	I-NP	O
Reflux	Reflux	NN	I-NP	O
HTN	HTN	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
CHF	CHF	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
EF	EF	NN	I-NP	O
65	65	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
for	for	IN	B-PP	O
diverticulitis	diverticulitis	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
S/P	S/P	NN	I-NP	B-protein
colectomy	colectomy	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
ventral	ventral	JJ	I-NP	I-protein
hernia	hernia	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
S/P	S/P	NN	I-NP	I-protein
hernia	hernia	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
carpal	carpal	JJ	I-NP	I-protein
tunnel	tunnel	NN	I-NP	I-protein
release	release	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
S/P	S/P	NN	I-NP	I-protein
carpal	carpal	JJ	I-NP	I-protein
tunnel	tunnel	NN	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CVA	CVA	NN	I-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ECHO	ECHO	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
pain	pain	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
--	--	:	O	O
HPI	HPI	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
81	81	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
PAF	PAF	NN	B-NP	B-protein
,	,	,	O	O
congenital	congenital	JJ	B-NP	O
non-fused	non-fused	JJ	I-NP	O
C1	C1	NN	I-NP	O
ring	ring	NN	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
L	L	NN	B-NP	B-protein
sided	sided	JJ	I-NP	I-protein
total	total	JJ	I-NP	I-protein
body	body	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
,	,	,	O	O
weakness	weakness	NN	B-NP	O
and	and	CC	O	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
started	start	VBD	B-VP	O
while	while	IN	B-SBAR	O
undergoing	undergo	VBG	B-VP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
L	L	NN	I-NP	O
shoulder	shoulder	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
balance	balance	NN	B-NP	O
problems	problem	NNS	I-NP	O
and	and	CC	O	O
difficulty	difficulty	NN	B-NP	O
ambulating	ambulate	VBG	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
chronic	chronic	JJ	B-NP	O
R	R	NN	I-NP	O
shoulder	shoulder	NN	I-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
CTA	CTA	NN	I-NP	O
in	in	IN	B-PP	O
6/12	6/12	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
neck	neck	NN	I-NP	O
CT	CT	NN	I-NP	O
6/12	6/12	CD	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
DJD	DJD	NNP	B-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
second	second	JJ	B-NP	O
PT	PT	NN	I-NP	O
visit	visit	NN	I-NP	O
on	on	IN	B-PP	O
Thursday	Thursday	NNP	B-NP	O
4/19	4/19	CD	I-NP	O
she	she	PRP	B-NP	O
awoke	awake	VBD	B-VP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
morning	morning	NN	I-NP	O
with	with	IN	B-PP	O
severe	severe	JJ	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
neck	neck	NN	I-NP	O
and	and	CC	O	O
head	head	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
neck	neck	NN	I-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
worse	worse	JJR	B-ADJP	O
with	with	IN	B-PP	O
extension	extension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
with	with	IN	B-PP	O
flexion	flexion	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
pain	pain	NN	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
L	L	NN	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
body	body	NN	I-NP	O
but	but	CC	O	O
specifically	specifically	RB	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
location	location	NN	I-NP	O
of	of	IN	B-PP	O
L	L	NN	B-NP	B-protein
LE	LE	NN	I-NP	I-protein
varicose	varicose	NN	I-NP	I-protein
veins	vein	NNS	I-NP	I-protein
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
feels	feel	VBZ	B-VP	O
alternating	alternate	VBG	I-VP	O
heat	heat	NN	B-NP	O
and	and	CC	I-NP	O
cold	cold	NN	I-NP	O
on	on	IN	B-PP	O
L	L	NN	B-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
body	body	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
reports	report	VBZ	B-VP	O
difficulty	difficulty	NN	B-NP	O
walking	walk	VBG	B-VP	O
well	well	RB	B-ADVP	O
now	now	RB	B-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
pain	pain	NN	B-NP	O
,	,	,	I-NP	O
weakness	weakness	NN	I-NP	O
,	,	,	I-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
taking	take	VBG	I-VP	O
tylenol	tylenol	NN	B-NP	O
for	for	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
helps	help	VBZ	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
reports	report	VBZ	B-VP	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
vomited	vomit	VBD	B-VP	O
yellow	yellow	JJ	B-NP	O
vomit	vomit	NN	I-NP	O
am	am	NN	I-NP	O
of	of	IN	B-PP	O
admit	admit	NN	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
positive	positive	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
for	for	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
DOE	DOE	NNP	B-NP	O
,	,	,	O	O
stable	stable	JJ	B-NP	O
two	two	CD	I-NP	O
pillow	pillow	NN	I-NP	O
orthopnea	orthopnea	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
loss	loss	NN	B-NP	O
of	of	IN	B-PP	O
balance	balance	NN	B-NP	O
,	,	,	O	O
eye	eye	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
night	night	NN	B-NP	O
time	time	NN	I-NP	O
coughing	coughing	NN	I-NP	O
,	,	,	O	O
subjective	subjective	JJ	B-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
abd	abd	NN	B-NP	O
girth	girth	NN	I-NP	O
,	,	,	O	O
headache	headache	NN	B-NP	O
and	and	CC	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
felt	feel	VBD	B-VP	O
progressively	progressively	RB	B-ADJP	O
worse	worse	JJR	I-ADJP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
weekend	weekend	NN	I-NP	O
and	and	CC	O	O
presented	present	VBN	B-VP	O
today	today	NN	B-NP	O
to	to	TO	B-PP	O
INRO	INRO	NN	B-NP	O
CHARLESTY	CHARLESTY	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
OF	OF	IN	B-PP	O
clinic	clinic	NN	B-NP	O
from	from	IN	B-PP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
DGH	DGH	NN	B-NP	B-protein
ER	ER	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bowel/bladder	bowel/bladder	NN	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
PMH	PMH	NN	B-NP	B-protein
:	:	:	O	I-protein
1	1	CD	B-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Diabetes	Diabetes	NNP	B-NP	O
Mellitus	Mellitus	NNP	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

HTN	HTN	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

CAD	CAD	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

PAF	PAF	NN	B-NP	B-protein
,	,	,	B-PP	O
not	not	RB	I-PP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

GIB	GIB	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

S/p	S/p	NN	B-NP	O
PPM	PPM	NN	I-NP	O
for	for	IN	B-PP	O
tachy/brady	tachy/brady	NN	B-NP	B-protein
syndrome	syndrome	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

H/O	H/O	NN	B-NP	B-protein
CVA	CVA	NN	I-NP	I-protein
8	8	CD	I-NP	I-protein
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

Diastolic	Diastolic	JJ	B-NP	B-protein
heart	heart	NN	I-NP	I-protein
dysfunction	dysfunction	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Hypercholesterolemia	Hypercholesterolemia	NN	B-NP	O
10	10	CD	I-NP	O
.	.	.	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O

H/O	H/O	NN	B-NP	O
SBO	SBO	NN	I-NP	O
s/p	s/p	NN	I-NP	O
LOA	LOA	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Osteoarthritis	Osteoarthritis	NN	B-NP	B-protein
12	12	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Diverticulitis	Diverticulitis	NN	B-NP	O
s/p	s/p	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Cataract	Cataract	NN	B-NP	B-protein
surgery	surgery	NN	I-NP	I-protein
14	14	CD	I-NP	I-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Hernia	Hernia	NNP	B-NP	O
repair	repair	NN	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O

Hysterectomy	Hysterectomy	NN	B-NP	O
--	--	:	O	O
MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Albuterol	Albuterol	NNP	B-NP	O
inhaler	inhaler	NNP	I-NP	O
prn	prn	NN	I-NP	O
Aquaphor	Aquaphor	NNP	I-NP	O
prn	prn	NN	I-NP	O
Aspirin	Aspirin	NNP	I-NP	O
325mg	325mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
Betamethasone	Betamethasone	NN	I-NP	O
Valerate	Valerate	NNP	B-NP	O
0.1	0.1	CD	B-NP	O
%	%	NN	I-NP	O
ointment	ointment	NN	I-NP	O
prn	prn	NN	I-NP	O
Calcium	Calcium	NN	I-NP	O
Carbonate	Carbonate	NN	I-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
Clobetasol	Clobetasol	NN	I-NP	O
Propionate	Propionate	NN	I-NP	O
0.05	0.05	CD	B-NP	O
%	%	NN	I-NP	O
top	top	JJ	I-NP	O
bid	bid	NN	I-NP	O
Colace	Colace	NNP	B-NP	O
100mg	100mg	CD	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
Digoxin	Digoxin	NN	I-NP	O
0.25	0.25	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
daily	daily	JJ	I-NP	O
Ferrous	Ferrous	JJ	I-NP	O
sulfate	sulfate	NN	I-NP	O
325mg	325mg	NN	I-NP	O
po	po	NN	I-NP	O
daily	daily	JJ	I-NP	O
Flonase	Flonase	NN	I-NP	O
2	2	CD	I-NP	O
spray	spray	NN	I-NP	O
NAS	NAS	NNP	B-NP	O
bid	bid	VBD	B-VP	O
Insulin	Insulin	NNP	B-NP	O
regular	regular	JJ	I-NP	O
8units	8unit	NNS	I-NP	O
qam	qam	VBP	B-VP	O
Insulin	Insulin	NN	B-NP	B-protein
regular	regular	JJ	I-NP	O
10units	10unit	NNS	I-NP	O
qpm	qpm	VBP	B-VP	O
Lasix	Lasix	NNP	B-NP	O
40mg	40mg	CD	I-NP	O
po	po	NN	I-NP	O
qam	qam	NN	I-NP	O
Lipitor	Lipitor	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
po	po	NN	I-NP	O
daily	daily	JJ	I-NP	O
Lopressor	Lopressor	NNP	I-NP	O
75mg	75mg	NN	I-NP	O
po	po	NN	I-NP	O
bid	bid	NN	I-NP	O
Lotrim	Lotrim	NNP	I-NP	O
cream	cream	NNP	I-NP	O
prn	prn	NN	I-NP	O
Miralax	Miralax	NNP	I-NP	O
prn	prn	VBP	B-VP	O
MVI	MVI	NNP	B-NP	O
daily	daily	JJ	I-NP	O
NTG	NTG	NNP	I-NP	O
SL	SL	NNP	I-NP	O
prn	prn	NN	I-NP	O
NPH	NPH	NN	I-NP	O
65units	65unit	NNS	I-NP	O
qam	qam	NN	I-NP	O
,	,	,	O	O
68units	68unit	VBZ	B-VP	O
qpm	qpm	NN	B-NP	O
Nystatin	Nystatin	NN	I-NP	O
powder	powder	NN	I-NP	O
bid	bid	NN	I-NP	O
Protonix	Protonix	NNP	B-NP	O
40mg	40mg	CD	I-NP	O
daily	daily	RB	B-ADVP	O
--	--	:	O	O
PE	PE	NN	B-NP	O
:	:	:	O	O
VS	VS	NN	B-NP	O
:	:	:	O	O
T96	T96	NN	B-NP	O
.7	.7	CD	I-NP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
66	66	CD	I-NP	I-protein
,	,	,	O	O
BP	BP	NN	B-NP	O
98/70	98/70	CD	I-NP	O
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
18	18	CD	I-NP	I-protein
,	,	,	O	O
O2	O2	NN	B-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
Sat	Sat	NN	I-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
GEN	GEN	NN	I-NP	I-protein
:	:	:	O	O
Comfortable	Comfortable	JJ	B-NP	O
,	,	,	I-NP	O
NAD	NAD	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRLA	PERRLA	NNP	B-NP	O
B	B	NNP	I-NP	O
,	,	,	O	O
EOMI	EOMI	NNP	B-NP	O
NECK	NECK	NNP	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
JVD	JVD	NN	I-NP	O
CHEST	CHEST	NN	I-NP	O
:	:	:	O	O
CTA	CTA	NN	B-NP	B-protein
bilaterally	bilaterally	RB	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
irregular	irregular	JJ	B-NP	O
,	,	,	I-NP	O
loud	loud	JJ	I-NP	O
SEM	SEM	NN	I-NP	O
ABD	ABD	NN	I-NP	O
:	:	:	O	O
+	+	SYM	B-NP	O
distended	distended	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
EXT	EXT	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pitting	pit	VBG	I-NP	O
edema	edema	NN	I-NP	O
bilat	bilat	NN	I-NP	O
SKIN	SKIN	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	O
or	or	CC	I-NP	O
lesions	lesion	NNS	I-NP	O
NEURO	NEURO	NN	I-NP	B-protein
:	:	:	O	O
CN	CN	NN	B-NP	O
II-XII	II-XII	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
focal	focal	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Strength	Strength	NN	B-NP	O
5/5	5/5	CD	I-NP	O
throughout	throughout	IN	B-ADVP	O
.	.	.	O	O

--	--	:	O	O
CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
overt	overt	JJ	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

--	--	:	B-NP	O
HEAD	HEAD	NN	I-NP	O
CTA	CTA	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

No	No	DT	B-NP	O
acute	acute	JJ	I-NP	B-protein
intracranial	intracranial	JJ	I-NP	I-protein
abnormality	abnormality	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
CT	CT	NN	I-NP	O
angiogram	angiogram	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
and	and	CC	I-NP	O
neck	neck	NN	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
occlusion	occlusion	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
aneurysm	aneurysm	NN	B-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Unchanged	Unchanged	JJ	B-NP	O
small	small	JJ	I-NP	O
basilar	basilar	JJ	I-NP	O
artery	artery	NN	I-NP	O
caliber	caliber	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Hypoplastic	Hypoplastic	JJ	B-NP	O
right	right	JJ	I-NP	O
V4	V4	NN	I-NP	B-protein
segment	segment	NN	I-NP	I-protein
.	.	.	O	O

--	--	:	O	O
Assessment	Assessment	NN	B-NP	O
and	and	CC	I-NP	O
Plan	Plan	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
81	81	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
medical	medical	JJ	I-NP	O
problems	problem	NNS	I-NP	O
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
vague	vague	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
likely	likely	RB	B-ADVP	O
has	have	VBZ	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
medical	medical	JJ	I-NP	O
issue	issue	NN	I-NP	O
going	go	VBG	B-VP	O
on	on	RP	B-PRT	O
simultaneously	simultaneously	RB	B-ADVP	O
.	.	.	O	O

--	--	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
ISCHEMIA	ISCHEMIA	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
CAD	CAD	NN	B-NP	B-protein
.	.	.	O	O

Worsening	Worsen	VBG	B-VP	O
angina	angina	NN	B-NP	O
with	with	IN	B-PP	O
exertion	exertion	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
s/s	s/	NNS	I-NP	O
of	of	IN	B-PP	O
ACS	ACS	NN	B-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
ST	ST	NN	I-NP	O
segment	segment	NN	I-NP	O
elevations	elevation	NNS	I-NP	O
.	.	.	O	O

Checked	Check	VBN	B-NP	O
set	set	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
PUMP	PUMP	NN	I-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
diastolic	diastolic	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

ECHO	ECHO	NN	B-NP	B-protein
over	over	IN	B-PP	O
one	one	CD	B-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
showed	show	VBD	B-VP	O
EF	EF	NN	B-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
of	of	IN	B-PP	O
DOE	DOE	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
LE	LE	NN	B-NP	O
swelling	swelling	NN	I-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
girth	girth	NN	I-NP	O
could	could	MD	B-VP	O
also	also	RB	I-VP	O
be	be	VB	I-VP	O
explained	explain	VBN	I-VP	O
by	by	IN	B-PP	O
Cor	Cor	NNP	B-NP	O
Pulmonale	Pulmonale	NNP	I-NP	O
or	or	CC	O	O
worsening	worsen	VBG	B-VP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CXR	CXR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
stable	stable	JJ	B-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
overt	overt	JJ	B-NP	O
edema	edema	NN	I-NP	O
but	but	CC	O	O
clinically	clinically	RB	B-ADVP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
elevated	elevated	JJ	I-NP	O
JVP	JVP	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
abd	abd	NN	B-NP	O
girth	girth	NN	I-NP	O
and	and	CC	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
were	be	VBD	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
fluid	fluid	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
low	low	JJ	B-ADJP	O
at	at	IN	B-PP	O
122	122	CD	B-NP	O
but	but	CC	O	O
likely	likely	RB	B-ADJP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
overloaded	overloaded	JJ	I-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
ECHO	ECHO	NN	I-NP	B-protein
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
elevated	elevated	JJ	B-NP	O
pulm	pulm	NN	I-NP	O
artery	artery	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
45	45	CD	B-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderately	moderately	RB	B-NP	O
enlarged	enlarged	JJ	I-NP	O
R	R	NN	I-NP	O
ventricle	ventricle	NN	I-NP	O
and	and	CC	O	O
moderately	moderately	RB	B-VP	O
enlarged	enlarge	VBD	I-VP	O
Right	Right	NN	B-NP	O
atrium	atrium	NN	I-NP	O
.	.	.	O	O

EF	EF	NN	B-NP	O
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
findings	finding	NNS	I-NP	O
are	be	VBP	B-VP	O
suggestive	suggestive	JJ	B-ADJP	O
of	of	IN	B-PP	O
potential	potential	JJ	B-NP	O
cor	cor	NN	I-NP	O
pulmonale	pulmonale	NN	I-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
diurese	diurese	VB	I-VP	O
pt	pt	NN	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
and	and	CC	I-NP	O
repeat	repeat	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
,	,	,	O	O
then	then	RB	O	O
consideration	consideration	NN	B-NP	O
of	of	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
referral	referral	NN	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
is	be	VBZ	B-VP	O
added	add	VBN	I-VP	O
as	as	IN	B-PP	O
allergy	allergy	NN	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
hyperkalemia	hyperkalemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
perhaps	perhaps	RB	B-ADVP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
as	as	IN	B-PP	O
small	small	JJ	B-NP	O
dose	dose	NN	I-NP	O
with	with	IN	B-PP	O
close	close	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

Defer	Defer	NN	B-NP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	B-DNA
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
strict	strict	JJ	B-NP	O
I/Os	I/O	NNS	I-NP	O
,	,	,	O	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

Avoided	Avoid	VBN	B-NP	O
fluid	fluid	NN	I-NP	O
restriction	restriction	NN	I-NP	O
given	give	VBN	B-VP	O
low	low	JJ	B-NP	O
BP	BP	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
RHYTHM	RHYTHM	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
raising	raise	VBG	B-VP	O
the	the	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
dig	dig	NN	B-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
afib	afib	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
came	come	VBD	B-VP	O
back	back	RB	B-ADVP	O
at	at	IN	B-PP	O
1.4	1.4	CD	B-NP	O
which	which	WDT	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
slightly	slightly	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
and	and	CC	O	O
muscle	muscle	NN	B-NP	O
mass	mass	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
digoxin	digoxin	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
therefore	therefore	RB	I-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
frequent	frequent	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
pacing	pacing	NN	I-NP	O
and	and	CC	O	O
occasional	occasional	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
.	.	.	O	O

--	--	:	O	O
ORTHO	ORTHO	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
had	have	VBD	B-VP	O
CT	CT	NN	B-NP	O
of	of	IN	B-PP	O
cervical	cervical	JJ	B-NP	O
spine	spine	NN	I-NP	O
in	in	IN	B-PP	O
October	October	NNP	B-NP	B-protein
'07	'07	CD	I-NP	I-protein
for	for	IN	B-PP	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
L	L	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
is	be	VBZ	B-VP	O
her	her	PRP$	B-NP	O
current	current	JJ	I-NP	O
presentation	presentation	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
DJD	DJD	NN	B-NP	O
but	but	CC	O	O
no	no	DT	B-NP	O
fracture	fracture	NN	I-NP	O
or	or	CC	O	O
other	other	JJ	B-NP	O
concerning	concern	VBG	I-NP	O
finding	finding	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
recent	recent	JJ	I-NP	O
trauma	trauma	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
from	from	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
DJD	DJD	NN	B-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
conservative	conservative	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
with	with	IN	B-PP	O
hotpacks	hotpack	NNS	B-NP	O
,	,	,	O	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
imaging	imaging	NN	I-NP	O
indicated	indicate	VBD	B-VP	O
.	.	.	O	O

Home	Home	NN	B-NP	O
PT	PT	NN	I-NP	O
planned	plan	VBN	B-VP	O
.	.	.	O	O

--	--	:	O	O
NEURO	NEURO	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
has	have	VBZ	B-VP	O
hx	hx	NN	B-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
but	but	CC	O	O
current	current	JJ	B-NP	O
CTA	CTA	NN	I-NP	O
shows	show	VBZ	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
acute	acute	JJ	B-NP	O
CVA	CVA	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
Neuro	Neuro	NNP	I-NP	O
exam	exam	NN	I-NP	O
is	be	VBZ	B-VP	O
fairly	fairly	RB	B-ADJP	O
unremarkable	unremarkable	JJ	I-ADJP	O
despite	despite	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
vague	vague	JJ	I-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
numbness	numbness	NN	B-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
asa	asa	NN	B-NP	O
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
exam	exam	NN	I-NP	O
monitored	monitor	VBN	B-VP	O
without	without	IN	B-PP	O
focal	focal	JJ	B-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

Treated	Treat	VBN	B-NP	O
headache	headache	NN	I-NP	O
with	with	IN	B-PP	O
Tylenol	Tylenol	NN	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
the	the	DT	B-NP	O
pt	pt	NN	I-NP	O
's	's	POS	B-NP	O
overall	overall	JJ	I-NP	O
pain	pain	NN	I-NP	O
persists	persist	VBZ	B-VP	O
,	,	,	O	O
she	she	PRP	B-NP	O
might	might	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
pain	pain	NN	B-NP	O
consult	consult	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
--	--	:	O	O
PULM	PULM	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
pulm	pulm	NN	I-NP	O
disease	disease	NN	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
prescribed	prescribe	VBN	I-VP	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
she	she	PRP	B-NP	O
in	in	IN	B-PP	O
fact	fact	NN	B-NP	O
has	have	VBZ	B-VP	O
pulm	pulm	NN	B-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
causative	causative	JJ	B-NP	O
pulm	pulm	NN	I-NP	O
etiology	etiology	NN	I-NP	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
pulm	pulm	NN	I-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
ECHO	ECHO	NN	B-NP	O
suggestive	suggestive	JJ	B-ADJP	O
,	,	,	O	O
PFTs	PFT	NNS	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
per	per	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

--	--	:	O	O
GI	GI	NN	B-NP	O
:	:	:	O	O
Bowel	Bowel	NNP	B-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

PPI	PPI	NN	B-NP	B-protein
for	for	IN	B-PP	O
GERD	GERD	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
ENDO	ENDO	NN	B-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
has	have	VBZ	B-VP	O
IDDM	IDDM	NN	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	O	O
exactly	exactly	RB	B-ADVP	O
clear	clear	JJ	B-ADJP	O
what	what	WP	B-NP	O
she	she	PRP	B-NP	O
takes	take	VBZ	B-VP	O
for	for	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
at	at	IN	B-PP	O
home	home	NN	B-NP	O
because	because	IN	B-SBAR	O
she	she	PRP	B-NP	O
reports	report	VBZ	B-VP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
only	only	RB	B-ADVP	O
takes	take	VBZ	B-VP	O
NPH	NPH	NN	B-NP	B-protein
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
despite	despite	IN	B-PP	O
the	the	DT	B-NP	O
prescription	prescription	NN	I-NP	O
in	in	IN	B-PP	O
WBMC	WBMC	NN	B-NP	B-cell_type
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
unclear	unclear	JJ	B-ADJP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
doses	dose	NNS	I-NP	O
or	or	CC	I-NP	O
timing	timing	NN	I-NP	O
of	of	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
hypoglycemic	hypoglycemic	JJ	B-ADJP	O
upon	upon	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

Check	Check	NN	B-NP	O
Hgb	Hgb	NN	I-NP	O
A1C	A1C	NN	I-NP	O
--	--	:	O	O
>	>	SYM	B-NP	O
7.4	7.4	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Sliding	Slide	VBG	B-NP	O
scale	scale	NN	I-NP	O
Novolog	Novolog	NNP	I-NP	O
and	and	CC	I-NP	O
AM	AM	NNP	I-NP	O
NPH	NPH	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
being	be	VBG	B-VP	O
.	.	.	O	O

Monitored	Monitor	VBN	B-NP	O
FS	FS	NNS	I-NP	O
which	which	WDT	B-NP	O
were	be	VBD	B-VP	O
reasonable	reasonable	JJ	B-ADJP	O
.	.	.	O	O

PCP	PCP	NN	B-NP	O
to	to	TO	B-VP	O
cont	cont	VB	I-VP	O
management	management	NN	B-NP	O
.	.	.	O	O

--	--	:	O	O
FEN	FEN	NN	B-NP	O
:	:	:	O	O
Monitored	Monitor	VBN	B-NP	O
fluid	fluid	NN	I-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Monitored	Monitor	VBN	B-NP	O
lytes	lyte	NNS	I-NP	O
.	.	.	O	O

Avoided	Avoid	VBN	B-NP	O
K	K	NN	I-NP	O
scale	scale	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
.	.	.	O	O

Low	Low	JJ	B-NP	O
fat	fat	NN	I-NP	O
,	,	,	O	O
Low	Low	JJ	B-NP	O
chol	chol	NN	I-NP	O
,	,	,	O	O
NAS	NAS	NNP	B-NP	O
,	,	,	O	O
carb	carb	NN	B-NP	O
controlled	control	VBD	B-VP	O
diet	diet	NN	B-NP	O
--	--	:	O	O
PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
Lovenox	Lovenox	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
medication	medication	NN	B-NP	O
reconcilliation	reconcilliation	NN	I-NP	O
.	.	.	O	O

VNA-please	VNA-please	NN	B-NP	B-protein
go	go	VBP	B-VP	O
through	through	IN	B-PP	O
all	all	DT	B-NP	O
medication	medication	NN	I-NP	O
bottles	bottle	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
house	house	NN	I-NP	O
and	and	CC	O	O
sort	sort	VB	B-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
ones	one	NNS	I-NP	O
,	,	,	O	O
help	help	NN	B-NP	O
patient	patient	NN	I-NP	O
make	make	VBP	B-VP	O
pill	pill	NN	B-NP	O
box	box	NN	I-NP	O
with	with	IN	B-PP	O
most	most	JJS	B-NP	O
current	current	JJ	I-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
dose	dose	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
lowered	lower	VBN	I-VP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
from	from	IN	B-PP	O
0.25	0.25	CD	B-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
0.125	0.125	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

Lasix	Lasix	NNP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
temporarily	temporarily	RB	B-ADVP	O
to	to	TO	B-PP	O
BID	BID	NN	B-NP	O
for	for	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
until	until	IN	B-SBAR	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
sodium	sodium	NN	B-NP	O
,	,	,	I-NP	O
potassium	potassium	NN	I-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
June	June	NNP	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

VNA	VNA	NN	B-NP	O
to	to	TO	B-VP	O
check	check	VB	I-VP	O
BP	BP	NN	B-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
bid	bid	NN	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Hold	Hold	JJ	B-NP	O
dose	dose	NN	I-NP	O
if	if	IN	B-SBAR	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	B-NP	O
95	95	CD	I-NP	O
and	and	CC	O	O
call	call	NN	B-NP	O
PCP	PCP	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Monitor	Monitor	NN	B-NP	O
fluid	fluid	NN	I-NP	O
status/electrolytes	status/electrolyte	NNS	I-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
ECHO	ECHO	NN	I-NP	O
after	after	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
Cardiology	Cardiology	NNP	B-NP	O
consult	consult	VB	B-VP	O
for	for	IN	B-PP	O
?	?	.	O	O

Cor	Cor	NNP	B-NP	O
Pulmonale	Pulmonale	NNP	I-NP	O
.	.	.	O	O

Monitor	Monitor	NN	B-NP	O
renal	renal	JJ	I-NP	O
function	function	NN	I-NP	O
and	and	CC	I-NP	O
digoxin	digoxin	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
NIGHTINGALE	NIGHTINGALE	NN	B-NP	O
,	,	,	O	O
BOYCE	BOYCE	NN	B-NP	O
,	,	,	O	O
PA-C	PA-C	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
IF08	IF08	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
7/28/07	7/28/07	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
33	33	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

